Journal Guide

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to such work in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: * drug, device, and biological research and development * drug screening and drug design * assessment of pharmacological activity * pharmaceutical formulation and scale-up * preclinical safety assessment * bioavailability, bioequivalence, and pharmacokinetics * phase, I, II, and III clinical development * premarket approval assessment of clinical safety * postmarketing surveillance Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.

DON'T MISS A BEAT!Every informative issue of the Journal of Cardiovascular Pharmacology and Therapeutics (JCPT) offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, JCPT examines and analyzes arenas such as: o Agents that Reduce Myocardial Infarct Size o Agents that Reduce Myocardial Remodeling o Angiotensin Converting Enzyme Inhibitors o Antihypertensive Therapy o Arrhythmias o Atrial Fibrillation o Beta-Blocker Therapies o Cardioembolic Stroke o Cardiomyopathy o Cardioprotective Agents o Cardiopulmonary Resuscitation o Cardiovascular Combination Therapies o Chronic Angina o Chronic Cardiac Ischemia o Congestive Heart Failure o Coronary Artery Disease o Coronary Revascularization o Heparin Therapies o Hypertension o Hypotension o Implantable Devices o Ischemic Heart Disease o Myocardial Infarction o Percutaneous Coronary Interventions o Peripheral Arterial Disease o Preconditioning/Postconditioning o Regenerative Cardiology o Stem Cell TherapyAmong the drug classes regularly evaluated are: ACE inhibitors * angiotensin receptor blockers * anti-anginals * anti-arrhythmics * anti-coagulants * anti-hypertensives * anti-thrombins * beta-blockers * calcium channel blockers * cardioprotective agents * cardiotonic agents * direct renin inhibitors * diuretics * fibrinolytic agents * heart rate modulats * plasminogen activators * QT prolonging drugs * statins * vasoconstrictor agents * and vasodilator agents.The journal features original articles, topical journal supplements, reviews, clinical and experimental investigations, and commentaries written by respected practitioners from all over the world.

SUBSCRIBE TO THE Journal of Chemotherapyto help keep you up-to-date on antimicrobial chemotherapy,anticancer chemotherapy, immunomodulating chemotherapy,experimental and clinical studies in these fields published bimonthly.

Journal of Child and Adolescent Psychopharmacology is a peer-reviewed journal covering the clinical aspects of treating adolescents and children with psychotropic medications. The Journal encompasses treatment techniques, clinical management, investigative research, and health policy.Coverage includes:• The most up-to-date information on new drugs and treatment strategies• Analysis of biological aspects of psychopathology• In-depth studies on the adverse drug effects following treatment of psychiatric disorders• Information on related areas of medical sciences• Related news and issues in child and adolescent psychopharmacology.

This leading publication in psychopharmacology offers a wide range of articles that report on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, medico-legal issues, and psychiatric effects of non-psychiatric drugs. The Journal keeps psychiatrists and psychiatric residents up-to-date on the latest clinical developments in the psychotropics, presenting the extensive coverage needed to keep up with every development in this fast-growing field. For more information, visit www.psychopharmacology.com.

THE JOURNAL OF DIETARY SUPPLEMENTS (formerly the Journal of Herbal Pharmacotherapy), is a leading voice in the dietary supplement industry. Published quarterly, the journal provides a much-needed forum to guide the industry’s development as a science-based entity. Under the leadership of Editor-in-Chief Catherine Ulbricht, founder of the Natural Standard Research Collaboration, JDS will keep you informed on the most up-to-date issues of the dietary supplement industry using rigorous scientific research and practical applications of that research. Read More: http://informahealthcare.com/loi/jds.

The Journal of Infection and Chemotherapy (JIC) publishes original papers, laboratory or clinical, as well as case reports and notes from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Offerings include experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials. The Journal of Infection and Chemotherapy is the official journal of the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases.

Journal of Ocular Pharmacology and Therapeutics is the only multidisciplinary peer-reviewed journal that covers basic and clinical research about biopharmaceuticals that have the potential to prevent, treat, and/or diagnose, ocular diseases and disorders.The Journal publishes manuscripts, reviews, and letters to the editor related to the pharmacokinetics and pharmacodynamics of biopharmaceuticals related to the treatment of the eye.

Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer. It is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP). Publishing pertinent case reports and consensus guidelines that drive clinical practice, this practical journal also includes information on new products, new therapies and patient management, as well as reviews of the latest research.

The Journal of Pain & Palliative Care Pharmacotherapy is an interdisciplinary, peer-reviewed, quarterly publication that addresses advances in acute, chronic, and end-of-life symptom management. It is published both in print and electronically (online). Readers in environments that have institutional subscriptions have access to full text of each issue online. The Journal of Pain & Palliative Care Pharmacotherapy is included in Medline/PubMed, EMBASE, and more than 50 other international abstracting & indexing services. Inside you’ll find original research, timely review articles, case reports, commentaries, book and media reviews, and articles on efficacy, safety, cost-effectiveness, availability, delivery systems, ethics, policy, philosophy, and other issues relevant to pharmacotherapy in the management of acute, chronic, and end-of-life pain and related symptoms. Readers are invited to submit letters to the Editor for publication consideration. The journal’s interdisciplinary, international, 32-member Editorial Board includes leading clinicians, investigators and analysts from the disciplines of bioethics, medicine, nursing, pharmaceutical sciences, psychology, social work, and health care policy. Read More: http://informahealthcare.com/page/ppc/Description.

Journal of Pharmacy Practice (JPP) offers practicing pharmacists in-depth, useful reviews of new drugs, new therapies, pharmacokinetics, drug administration, and adverse drug reactions. Each informative issue focuses on a vital topic in current pharmacy practice and pharmaceutical care, and includes reviews, research articles, reports of adverse drug events, hands-on pharmacy education articles, and the New York State Council of Health-system Pharmacists Section.

he Journal of Psychiatry & Neuroscience publishes original research articles and review papers in psychiatry and in neuroscience that advance our understanding of the mechanisms involved in the etiology and treatment of psychiatric disorders. This includes studies on patients with psychiatric disorders, healthy humans, and experimental animals as well as studies in vitro.The Journal of Psychiatry & Neuroscience is the highest-ranking free access journal in the psychiatry and neuroscience categories monitored by the Institute for Scientific Information.The Journal of Psychiatry & Neuroscience is published by the Canadian Medical Association. All editorial matter in the journal represents the opinions of the authors and not necessarily those of the Canadian Medical Association.The Canadian Medical Association assumes no responsibility or liability for damages arising from any error or omission, or from use of any information or advice contained in the journal, including articles, editorials, reviews, abstracts, letters and advertisements.

Essential ReadingThe Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.International ForumThe Journal of Psychopharmacology is truly international in scope and readership. This is reflected by its editorial board which has brought together the very best of clinical and preclinical psychopharmacology from around the world.Regular FeaturesPublished monthly, the Journal of Psychopharmacology provides readers with an extensive array of regular features, including: * Original Research - original scientific papers addressing preclinical and clinical aspects of psychopharmacology * Critique - papers on topics of general interest and importance written by experts, commentaries by other authorities and their rejoinders provide the reader with a rounded understanding of the issues involved * Perspectives - pithy, thought-provoking, short and focused reviews * Letters - facilitating an ongoing dialogue on key issues of psychopharmacology, the letters address issues raised by published articles, or report significant new findings that merit rapid dissemination The Journal of Psychopharmacology is published monthly. The Journal regularly includes supplementary issues for subscribers at no extra cost. A Full Range of Custom Services The Journal of Psychopharmacology provides an excellent international platform from which to present important clinical and pre-clinical research and an effective way to promote key products to your target audience in supplement or reprint formats. The journal offers the full range of custom services to meet your individual printing requirements, including: Journal Supplements - Rapidly produced (under 12 weeks from acceptance to delivery) and competitively priced, should you wish to sponsor an entire Supplement of new and original research material. All supplements are peer reviewed. Reprints and author offprints - Including customized gloss laminate covers and full printing to requirements, saddle-stitched binding and standard shrink-wrapping at no additional cost. These can be used for: o Sales support materials o Exhibit and meeting handouts o Direct mail inserts o Physician education o Seminar literature o Educational tools o Collections of articles on particular topics o Sponsored subscription opportunities o Translations o Advertising - Including conference listings and related events and launches o Discounts - For multiple orders and advance orders in a one year period.